cancer

Trial By Error: Why Did the NIH List an Award for Research on Cancer-Related Fatigue in Its List of Spending on ME/CFS?

By David Tuller, DrPH*April is crowdfunding month at UC Berkeley. If you like my work, consider making a tax-deductible donation to Berkeley’s School of Public Health to support the Trial By Error project:  https://crowdfund.berkeley.edu/project/37217 Each year, the US National Institutes of Health publishes its “estimates of funding for various research, condition, and disease categories.” These estimates …

Trial By Error: Why Did the NIH List an Award for Research on Cancer-Related Fatigue in Its List of Spending on ME/CFS? Read More »

An mRNA Vaccine to Treat Cancer

by Gertrud U. Rey There are several highly effective vaccines that block infection by human papillomaviruses (HPVs) and thereby prevent the cervical, anogenital, and head and neck cancers caused by these viruses. However, none of these vaccines are effective for the treatment of established HPV-induced tumors. The success of the COVID-19 messenger RNA (mRNA) vaccines …

An mRNA Vaccine to Treat Cancer Read More »

TWiV 531: Circ du RNA

Patrick Moore returns to TWiV to discuss the discovery from the Chang-Moore laboratory of circular RNAs in cells infected with herpesviruses. Click arrow to play Download TWiV 530 (65 MB .mp3, 107 min) Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Show notes at microbe.tv/twiv

A new function for oncoproteins of DNA tumor viruses

Oncogenes of DNA tumor viruses encode proteins that cause cells to divide incessantly, eventually leading to formation of a tumor. These oncoproteins have now been found to antagonize the innate immune response of the cell (link to paper). Most cells encountered by viruses are not dividing, and hence do not efficiently support viral DNA synthesis. The …

A new function for oncoproteins of DNA tumor viruses Read More »

Scroll to Top